购物车
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Autophagy
    (1)
  • DNA/RNA Synthesis
    (1)
  • Mitophagy
    (1)
  • PARP
    (1)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (1)
  • 5日内发货
    (1)
  • 4-6周
    (1)
TargetMol | Tags 通过 研究领域 筛选
  • 癌症研究
    (2)
抑制剂&激动剂
细分筛选
搜索结果
TargetMol产品目录中 "olaparib-d-5"的结果
筛选
搜索结果
TargetMol产品目录中 "

olaparib-d-5

"的结果
  • 抑制剂&激动剂
    3
    抑制剂&激动剂
  • 同位素
    2
    同位素
  • 标准品
    1
    标准品
  • Olaparib-D5
    Olaparib D5, KU0059436 D5, AZD2281 D5
    T122922143107-56-4
    Olaparib-D5 is a deuterium labeled Olaparib. Olaparib (T3015) is a potent and oral inhibitor of PARP.
    • ¥ 2190
    5日内发货
    规格
    数量
  • Olaparib-D5 (Standard)
    化合物 Olaparib-d5 (标准品), 奥拉帕尼-[d5] (标准品), Olaparib-[D5] (Standard)
    TMSM-65642143107-56-4
    Olaparib-D5 (Standard) 是 Olaparib-D5 的标准品,适用于定量分析、质量控制及生化实验等相关研究。
    • 待询
    规格
    数量
  • CAY10760
    T36703391889-85-3
    CAY10760 is an inhibitor of the protein-protein interaction between RAD51 recombinase and BRCA2 (EC50= 19 μM in a cell-free competitive ELISA).1It decreases homologous recombination by 54% in wild-typeBRCA2-expressing BxPC-3 pancreatic cancer cells when used at a concentration of 20 μM. CAY10760 (20 μM) decreases proliferation of BxPC-3, as well as mutantBRCA2-expressing Capan-1, cancer cells when used alone or in combination with the poly(ADP-ribose) polymerase (PARP) inhibitor olaparib . 1.Bagnolini, G., Milano, D., Manerba, M., et al.Synthetic lethality in pancreatic cancer: Discovery of a new RAD51-BRCA2 small molecule disruptor that inhibits homologous recombination and synergizes with olaparibJ. Med. Chem.63(5)2588-2619(2020)
    • ¥ 749
    现货
    规格
    数量